Advertisement

Special Situations in the Management of Hypertension

  • William J. Elliott
  • Henry R. Black
Part of the Atlas of Heart Diseases book series (AD)

Abstract

The modern physician is charged with integrating the art and science of medicine by extrapolating the results of physiologic studies and clinical trials to individual patients. Indeed, it could be argued that every clinical encounter is a “special situation” that deserves “special consideration.” Nonetheless, there are clearly circumstances in which the usual rubrics that are used in diagnosis and treatment must be modified. This is particularly true when the patient falls into the extremes in terms of demographic groups (eg, childhood or old age), when blood pressure (BP) is particularly high (eg, hypertensive emergencies), or when BP measurement is accomplished using techniques other than the indirect sphygmomanometric determinations in the physician’s office. This chapter attempts to address some of these special situations.

Keywords

High Blood Pressure Ambulatory Blood Pressure Ambulatory Blood Pressure Monitoring Systolic Hypertension Home Blood Pressure 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. 1.
    Moutquin JM, Rainville C, Giroux L, et al.: A prospective study of blood pressure in pregnancy: prediction of preeclampsia. Am J Obstet Gynecol 1985, 151: 191–196.PubMedGoogle Scholar
  2. 2.
    Sibai BM, Ewell M, Levine RJ, et al.: Risk Factors associated with preeclampsia in healthy nulliparous women. The Calcium for Preeclampsia Prevention (CPEP) Study Group. Am J Obstet Gynecol 1997, Nov:177(5): 1003–1010.PubMedCrossRefGoogle Scholar
  3. 3.
    Friedman SA: Preeclampsia: a review of the role of prostaglandins. Obstet Gynecol 1988, 71: 122–137.PubMedGoogle Scholar
  4. 4.
    Davey DA, MacGillivray I: The classification and definition of the hypertensive disorders of pregnancy. Am J Obstet Gynecol 1988, 158: 892–898.PubMedGoogle Scholar
  5. 5.
    Lubbe WF: Hypertension in pregnancy: pathophysiology and management. Drugs 1984, 28: 170–188.PubMedCrossRefGoogle Scholar
  6. 6.
    National High Blood Pressure Education Program Working Group on High Blood Pressure in Pregnancy: Working group report on high blood pressure in pregnancy. Am J Obstet Gynecol 1990, 163: 1689–1712.Google Scholar
  7. 7.
    Belizan J, Villar J, Gonzalez L, et al.: Calcium supplementation to prevent hypertensive disorders of pregnancy. N Engl J Med 1991, 325: 1399–1405.PubMedCrossRefGoogle Scholar
  8. 8.
    Bucher HC, Guyatt GH, Cook RJ, et al.: Effect of calcium supplementation on pregnancy-induced hypertension and preeclampsia: a meta-analysis of randomized controlled trials. JAMA 1996, 275: 1113–1117.PubMedCrossRefGoogle Scholar
  9. 9.
    Levine RJ, Hauth JC, Curet LB, et al.: Trial of calcium to prevent preeclampsia. N Engl J Med 1997, Jul 10:337(2): 69–76.PubMedCrossRefGoogle Scholar
  10. 10.
    Caritis S, Sibai B, Hauth J, et al.: Low-dose aspirin to prevent preeclampsia in women at high risk. National Institute of Child Health and Human Development Network of Maternal-Fetal Medicine Units. N Engl J Med 1998, Mar 12:338(11): 701–705.PubMedCrossRefGoogle Scholar
  11. 11.
    Update on the Task Force Report (1987) on High Blood Pressure in Children and Adolescents: A Working Group Report from the National High Blood Pressure Education Program. Pediatrics 1996, 98: 649–658.Google Scholar
  12. 12.
    Wilking SV, Belanger A, Kannel WB, et al.: Determinants of isolated systolic hypertension. JAMA 1988, 260: 3451–3455.PubMedCrossRefGoogle Scholar
  13. 13.
    Alli C, Avanzini F, Bettelli G, et al.: The long-term prognostic significance of repeated blood pressure measurements in the elderly: SPAA (Studio sulla Pressione Arteriosa nell’Anziano) 10-year follow-up. Arch Intern Med 1999, Jun 14:159(11): 1205–1212.PubMedCrossRefGoogle Scholar
  14. 14.
    Elliott WJ: Which blood pressure measurement is more important in the elderly? Arch Intern Med 1999, Jun 14:159(11): 1165–1166.PubMedCrossRefGoogle Scholar
  15. 15.
    Whelton PK, Appel LJ, Espeland MA, et al.: Sodium reduction and weight loss in the treatment of hypertension in older persons: a randomized controlled trial of nonpharmacologic interventions in the elderly (TONE). TONE Collaborative Research Group. JAMA 1998, Mar 18:279(11): 839–846.PubMedCrossRefGoogle Scholar
  16. 16.
    Insua JT, Sacks HS, Lau TS, et al.: Drug treatment of hypertension in the elderly: a meta-analysis. Ann Intern Med 1994, 121: 355–362.PubMedGoogle Scholar
  17. 17.
    Mulrow CD, Cornell JA, Herrera CR, et al.: Hypertension in the elderly: implications and generalizations of randomized trials. JAMA 1994, 272: 1932–1938.PubMedCrossRefGoogle Scholar
  18. 18.
    Gueyffier F, Bulpitt C, Boissel JP, et al.: Antihypertensive drugs in very old people: a subgroup meta-analysis of randomised controlled trials. INDANA Group Lancet 1999, Mar 6:353(9155): 793–796.PubMedCrossRefGoogle Scholar
  19. 19.
    Maclure M, Dormuth C, Naumann T, et al.: Influences of educational interventions and adverse news about calcium-channel blockers on first-line prescribing of antihypertensive drugs to elderly people in British Columbia. Lancet 1998, Sep 19:352(9132): 943–948.PubMedCrossRefGoogle Scholar
  20. 20.
    Sheps SG: The sixth report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure (JNC VI). Arch Intern Med 1997, 157: 2413–2446.CrossRefGoogle Scholar
  21. 21.
    Johansson B, Strandgaard S, Lassen NA: The hypertensive “breakthrough” of autoregulation of cerebral blood flow with forced vasodilatation, flow increase, and blood-brain barrier damage. Circ Res 1974, 34-35(suppl I): 167–171.Google Scholar
  22. 22.
    Elliott WJ: Malignant hypertension. In Principles of Critical Care. Edited by Hall JB, Schmidt GA, Wood LDH. New York: McGraw-Hill; 1992: 1563–1571.Google Scholar
  23. 23.
    SHEP Cooperative Research Group: Prevention of stroke by antihypertensive drug treatment in older persons with isolated systolic hypertension: final results of the Systolic Hypertension in the Elderly Program. JAMA 1991, 265: 3255–3264.CrossRefGoogle Scholar
  24. 24.
    Toumilehto J, Rastenyte D, Birkenhager WH, et al for the Systolic Hypertension Europe (Syst-Eur) Trial Investigations: Effect of calcium channel blockade in older patients with diabetes and systolic hypertension. N Engl J Med 1999, 340: 677–684.CrossRefGoogle Scholar
  25. 25.
    Psaty BM, Furberg CD, Kuller LH, et al.: Isolated systolic hypertension and subclinical cardiovascular disease in the elderly: initial findings from the Cardiovascular Health Study. JAMA 1992, 268: 1287–1291.PubMedCrossRefGoogle Scholar
  26. 26.
    Sagie A, Larson MG, Levy D: The natural history of borderline isolated systolic hypertension. N Engl J Med 1993, 329: 1912–1917.PubMedCrossRefGoogle Scholar
  27. 27.
    Bots ML, Witteman JCM, Hofman A, et al.: Low diastolic blood pressure and atherosclerosis in elderly subjects. Arch Intern Med 1995, 156: 843–848.CrossRefGoogle Scholar
  28. 28.
    Hoyert DL, Kochanek KD, Murphy SL: Deaths:final data for 1997. Natl Vital Stat Rep 1999, Jun 30:49(19): 1–104.Google Scholar
  29. 29.
    Klag MJ, Whelton PK, Randall BL, et al.: End-stage renal disease in African-American and white men. l6-year MRFIT findings. JAMA 1997, Apr23-30:277(16): 1293–1298.PubMedCrossRefGoogle Scholar
  30. 30.
    Hypertension Detection and Follow-up Cooperative Group: Persistence of reduction in blood pressure and mortality in participants in the Hypertension Detection and Follow-up Program. JAMA 1988, 259: 2113–2122.CrossRefGoogle Scholar
  31. 31.
    Saunders E, Weir MR, Kong BW, et al.: A comparison of the efficacy and safety of a ß-blocker, a calcium channel blocker, and a converting enzyme inhibitor in hypertensive blacks. Arch Intern Med 1990, 150: 1707–1713.PubMedCrossRefGoogle Scholar
  32. 32.
    Taler SJ, Textor SC, Canzanello VJ, et al.: Cyclosporin-induced hypertension: incidence, pathogenesis and management. Drug Saf 1999, May:20(5): 437–449.PubMedCrossRefGoogle Scholar
  33. 33.
    Curtis JJ: Posttransplant hypertension. Transplant Proc 1998, Aug:30(5): 2009–2011.PubMedCrossRefGoogle Scholar
  34. 34.
    Vaziri ND: Mechanism of erythropoietin-induced hypertension. Am J Kidney Dis 1999, May:33(5): 821–828.PubMedCrossRefGoogle Scholar
  35. 35.
    Williams RG, Kavanagh KM, Teo KK: Pathophysiology and treatment of cocaine toxicity: implications for the heart and cardiovascular system. Can J Cardiol 1996, Dec:12(12): 1295–1301.PubMedGoogle Scholar
  36. 36.
    Frolich ED, Grim C, Labarthe DR, et al.: Recommendations for human blood pressure determination by sphygmomanometers: report of a special task force appointed by the Steering Committee, American Heart Association. Hypertension 1988, 11: 210A–222A.Google Scholar
  37. 37.
    Gretler DD, Fumo MT, Nelson KS, et al.: Ethnic differences in circadian hemodynamic profile. Am J Hypertension 1994, 7: 7–14.Google Scholar
  38. 38.
    Staessen JA, O’Brien ET, Atkins N, et al.: On behalf of the Ad-Hoc Working Group: Short report: ambulatory blood pressure in normotensive compared with hypertensive subjects. J Hypertens Suppl 1994, 12(suppl): S1–S12.PubMedGoogle Scholar
  39. 39.
    Staessen JA, Thijs L, Fagard R, et al.: Predicitng cardiovascular risk using conventional vs ambulatory blood pressure in older patients with systolic hypertension. Systolic Hypertension in Europe Trial Investigators. JAMA 1999, Aug 11:282(6): 539–546.PubMedCrossRefGoogle Scholar
  40. 40.
    National High Blood Pressure Education Working Group: Report on ambulatory blood pressure monitoring. Arch Intern Med 1990, 150: 2270–2280.CrossRefGoogle Scholar
  41. 41.
    White WB, Schulman P, McCabe EJ, et al.: Average daily blood pressure, not office blood pressure, determines cardiac function in patients with hypertension. JAMA 1989, 261: 873–877.PubMedCrossRefGoogle Scholar
  42. 42.
    Perloff D, Sokolow M, Cowan R: The prognostic value of ambulatory blood pressures. JAMA 1983, 249: 2792–2798.PubMedCrossRefGoogle Scholar
  43. 43.
    Verdecchia P, Porcellati C, Schillaci G, et al.: Ambulatory blood pressure. An independent predictor of prognosis in essential hypertension. Hypertension 1994, 24: 793–801.PubMedCrossRefGoogle Scholar
  44. 44.
    Pickering TG for an American Society of Hypertension Ad Hoc Panel: Recommendations for the use of home (self) ambulatory blood pressure monitoring Am J Hypertens 1996, 9: 1–11.CrossRefGoogle Scholar
  45. 45.
    Appel LJ, Stason WB: Ambulatory blood pressure monitoring and blood pressure self-measurement in the diagnosis and management of hypertension. Ann Intern Med 1993, 118: 867–882.PubMedGoogle Scholar

Copyright information

© Springer Science+Business Media New York 2001

Authors and Affiliations

  • William J. Elliott
  • Henry R. Black

There are no affiliations available

Personalised recommendations